Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing.
Cannabis
Cognitive interviewing
Marijuana
Measurement assessment
Qualitative
Survey development
THC
Journal
Drug and alcohol dependence reports
ISSN: 2772-7246
Titre abrégé: Drug Alcohol Depend Rep
Pays: Netherlands
ID NLM: 9918350383506676
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
06
12
2022
revised:
16
03
2023
accepted:
15
04
2023
medline:
14
5
2023
pubmed:
14
5
2023
entrez:
14
5
2023
Statut:
epublish
Résumé
The diversity in characteristics of cannabis products and behavior patterns make evaluation of cannabis exposure in population-based, self-report surveys challenging. Accurate identification of cannabis exposure and related outcomes necessitates a thorough understanding of participants' interpretations of survey questions assessing cannabis consumption behaviors. The current study utilized cognitive interviewing to gain insight on participants' interpretation of items in a self-reported survey instrument used to estimate the quantity of THC consumed in population samples. Cognitive interviewing was used to evaluate survey items assessing cannabis use frequency, routes of administration, quantity, potency, and perceived "typical patterns" of use. Ten participants ≥18 years ( While most items presented no issues with comprehension, participants identified several areas of ambiguity in question or response item wording or in visual cues included in the survey. Generally, participants with irregular use patterns (i.e., non-daily use) reported more difficulty recalling the time or quantity of cannabis use. Findings resulted in several changes to the updated survey, including updated reference images and new quantity/frequency of use items specific to the route of administration. Incorporating cognitive interviewing into cannabis measurement development among a sample of knowledgeable cannabis consumers led to improvements in assessing cannabis exposure in population surveys, which may otherwise have been missed.
Sections du résumé
Background
UNASSIGNED
The diversity in characteristics of cannabis products and behavior patterns make evaluation of cannabis exposure in population-based, self-report surveys challenging. Accurate identification of cannabis exposure and related outcomes necessitates a thorough understanding of participants' interpretations of survey questions assessing cannabis consumption behaviors.
Objectives
UNASSIGNED
The current study utilized cognitive interviewing to gain insight on participants' interpretation of items in a self-reported survey instrument used to estimate the quantity of THC consumed in population samples.
Methods
UNASSIGNED
Cognitive interviewing was used to evaluate survey items assessing cannabis use frequency, routes of administration, quantity, potency, and perceived "typical patterns" of use. Ten participants ≥18 years (
Results
UNASSIGNED
While most items presented no issues with comprehension, participants identified several areas of ambiguity in question or response item wording or in visual cues included in the survey. Generally, participants with irregular use patterns (i.e., non-daily use) reported more difficulty recalling the time or quantity of cannabis use. Findings resulted in several changes to the updated survey, including updated reference images and new quantity/frequency of use items specific to the route of administration.
Conclusion
UNASSIGNED
Incorporating cognitive interviewing into cannabis measurement development among a sample of knowledgeable cannabis consumers led to improvements in assessing cannabis exposure in population surveys, which may otherwise have been missed.
Identifiants
pubmed: 37179574
doi: 10.1016/j.dadr.2023.100161
pii: S2772-7246(23)00031-8
pmc: PMC10173391
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100161Subventions
Organisme : NIDA NIH HHS
ID : R01 DA050032
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA037202
Pays : United States
Informations de copyright
© 2023 Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Alan Budney has served as a scientific consultant for Canopy Growth, Inc. and Jazz Pharmaceuticals.
Références
Drug Alcohol Depend. 2018 Jan 1;182:1-7
pubmed: 29112827
Int J Drug Policy. 2022 Jul;105:103716
pubmed: 35613480
Addiction. 1995 May;90(5):607-14
pubmed: 7795497
Addiction. 2020 Jul;115(7):1207-1216
pubmed: 31606008
Can J Public Health. 2018 Jan 22;108(5-6):e516-e522
pubmed: 29356658
Pain Res Manag. 2005 Autumn;10 Suppl A:15A-22A
pubmed: 16237477
Cannabis Cannabinoid Res. 2022 Dec 26;:
pubmed: 36577020
Eur Addict Res. 2014;20(5):254-67
pubmed: 25196945
Nicotine Tob Res. 2016 Oct;18(10):1998-2005
pubmed: 27029822
Addiction. 2020 Jul;115(7):1219-1221
pubmed: 32083354
Int J Drug Policy. 2020 Feb 26;77:102698
pubmed: 32113149
Subst Use Misuse. 2016 Nov 9;51(13):1760-70
pubmed: 27556867
Memory. 1998 Jul;6(4):339-66
pubmed: 9829096
Drug Alcohol Depend. 2019 Jan 1;194:500-517
pubmed: 30530238
CMAJ. 2020 Feb 18;192(7):E162
pubmed: 32071107
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
Int J Drug Policy. 2016 Oct;36:141-7
pubmed: 26992484
Addiction. 2022 Jun;117(6):1510-1517
pubmed: 34590359
Eur Addict Res. 2012;18(4):193-200
pubmed: 22472963
Qual Health Res. 2019 Aug;29(10):1474-1482
pubmed: 30600773
PLoS One. 2017 May 26;12(5):e0178194
pubmed: 28552942
Prev Med. 2020 Feb;131:105956
pubmed: 31863787
Drug Alcohol Rev. 2003 Sep;22(3):309-15
pubmed: 15385225
Annu Rev Food Sci Technol. 2020 Mar 25;11:45-70
pubmed: 31905012
Am J Addict. 2009 Mar-Apr;18(2):178-9
pubmed: 19283572
Cannabis Cannabinoid Res. 2022 Dec 15;:
pubmed: 36521175